BibTex RIS Kaynak Göster

Paraneoplastik sendromlar

Yıl 2001, Cilt: 7 Sayı: 1-2, 156 - 159, 01.06.2001

İsmail Alkan Loğman Aslan

Öz

Bu makalede paraneoplastik sendromların tanımı, çeşitleri, semptomları ve sağaltım ilkeleri kısaca değerlendirilmiştir

Anahtar Kelimeler

Kanser Paraneoplastik sendrom

Kaynakça

  • 1. Dobson JM. Gorman NT: Paraneoplastic syndromes. “R A S White (ed): Manııal of Smal Animal Oncology”, p81, BSAVA, (1991).
  • 2. Ogilvie GK: Paraneoplastic syndromes. "S J Ettinger, E C Feldam (ed): Textbook of Veterinary Internal Medicine” p513, WB Saunders Co, Philadelphia, (1995).
  • 3. Ogilvie GK: Paraneoplastic syndromes. “S J Witrow, E G McEwen (ed): Clinical Veterinary Oncology” p29, JB Lippincott, Philadelphia, (1989).
  • 4. Meuten DJ: Hypercalcemia, Vet Clin North Am 14:891(1984).
  • 5. Kruger JM, Osborne CA, Polzin DJ: Treatment of hypercalcemia. “R W Kirk (ed): Current Veterinary Therapy IX" p75, WB Saunders Co, Philadelphia. (1986).
  • 6. Lowitz BB: Paraneoplastic syndromes. “C M Haskell (ed): Cancer Treatment” p841, 3 Ü1 Ed, WB Saunders Co, Philadelphia, (1990).
  • 7. Leifer CE, Peterson ME: Hypoglycemia. Vet Clin North Am 14: 873,(1984).
  • 8. Meyer DJ, Coles EH, Rich LJ: Veterinary Laboratory Medicine. Interpretation and Diagnosis, p 12, WB Saunders Co, Philadelphia, (1992).
  • 9. Ogilvie GK, Vail DM: Unique metabolic alterations associated with cancer cachexia in dog. “RW Kirk (ed): Current Veterinary Therapy XI” p433, WB Saunders Co, Philadelphia, (1992).
  • 10. Ogilvie GK, Ford RD, Vail DM: Alterations in lipoprotein profiles in dogs with lymphoma, J Vet Intern Med 4: 8, (1994).
  • 11. Ogilvie GK: Metabolic alterations and nutritional therapy for the veterinary cancer patient, Comp Contin Ed 15: 925-936, (1993).
  • 12. Giger U, Gorman NT: Acute complications of cancer therapy. “N T Gorman (ed): Oncology” pl47, Chuıchill Livingstone, New York, (1986).
  • 13. Ogilvie GK. Haschek WA, McKierman B, Withıow SJ, Richaıdson RC: Classification of primary lung tumors in dog: 210cases (1975- 1985), JAVMA 195; 106, (1989).
  • 14. Bilezikian JP: Management of acute hypercalcemia, N Engl J Med 18:1196, (1992).
  • 15. Chlebowski RT, Heber D: Metebolic abnormalities in cancer patients: caıbohydrate metabolism, Suıg Clin North Am 66: 957, (1986).
  • 16. Weir EC, Nordin RW, Matus RE: Humoral hypercalcemia of malignancy in canine lymphosarcoma. Endocrinology 122 :602, (1988).
  • 17. Leifer CE, Peteıson ME, Matus RE, Patnaik AK: Hypoglycemia associated with non-isle-cell tumors in 13 dogs, JAVMA 186:53,(1985).
  • 18. Ogilvie GK, Felsberg PJ. Harris SW: Short term effect of cyclophosphamide and azathioprine on the selected aspects of the canine immune system, J Vet Immunol Iınmunopathol 18: 119,(1988).
  • 19. Ogilvie GK, Walters LM, Fettman MJ: Energy expenditure in dogs with lymphoma fed two specialized diets, Cancer 71:31- 46,(1993).
  • 20. Krishnaswamy K: Effects of malnutrion on drug metabolism and toxicity in humans, Nurt Toxicol 2:105, (1987).

Paraneoplastic syndromes

Yıl 2001, Cilt: 7 Sayı: 1-2, 156 - 159, 01.06.2001

İsmail Alkan Loğman Aslan

Öz

In this article, the definition, variety, symptoms, and treatment principles of paraneoplastic syndrome were reviewed

Anahtar Kelimeler

Cancer Paraneoplastic syndrome

Kaynakça

  • 1. Dobson JM. Gorman NT: Paraneoplastic syndromes. “R A S White (ed): Manııal of Smal Animal Oncology”, p81, BSAVA, (1991).
  • 2. Ogilvie GK: Paraneoplastic syndromes. "S J Ettinger, E C Feldam (ed): Textbook of Veterinary Internal Medicine” p513, WB Saunders Co, Philadelphia, (1995).
  • 3. Ogilvie GK: Paraneoplastic syndromes. “S J Witrow, E G McEwen (ed): Clinical Veterinary Oncology” p29, JB Lippincott, Philadelphia, (1989).
  • 4. Meuten DJ: Hypercalcemia, Vet Clin North Am 14:891(1984).
  • 5. Kruger JM, Osborne CA, Polzin DJ: Treatment of hypercalcemia. “R W Kirk (ed): Current Veterinary Therapy IX" p75, WB Saunders Co, Philadelphia. (1986).
  • 6. Lowitz BB: Paraneoplastic syndromes. “C M Haskell (ed): Cancer Treatment” p841, 3 Ü1 Ed, WB Saunders Co, Philadelphia, (1990).
  • 7. Leifer CE, Peterson ME: Hypoglycemia. Vet Clin North Am 14: 873,(1984).
  • 8. Meyer DJ, Coles EH, Rich LJ: Veterinary Laboratory Medicine. Interpretation and Diagnosis, p 12, WB Saunders Co, Philadelphia, (1992).
  • 9. Ogilvie GK, Vail DM: Unique metabolic alterations associated with cancer cachexia in dog. “RW Kirk (ed): Current Veterinary Therapy XI” p433, WB Saunders Co, Philadelphia, (1992).
  • 10. Ogilvie GK, Ford RD, Vail DM: Alterations in lipoprotein profiles in dogs with lymphoma, J Vet Intern Med 4: 8, (1994).
  • 11. Ogilvie GK: Metabolic alterations and nutritional therapy for the veterinary cancer patient, Comp Contin Ed 15: 925-936, (1993).
  • 12. Giger U, Gorman NT: Acute complications of cancer therapy. “N T Gorman (ed): Oncology” pl47, Chuıchill Livingstone, New York, (1986).
  • 13. Ogilvie GK. Haschek WA, McKierman B, Withıow SJ, Richaıdson RC: Classification of primary lung tumors in dog: 210cases (1975- 1985), JAVMA 195; 106, (1989).
  • 14. Bilezikian JP: Management of acute hypercalcemia, N Engl J Med 18:1196, (1992).
  • 15. Chlebowski RT, Heber D: Metebolic abnormalities in cancer patients: caıbohydrate metabolism, Suıg Clin North Am 66: 957, (1986).
  • 16. Weir EC, Nordin RW, Matus RE: Humoral hypercalcemia of malignancy in canine lymphosarcoma. Endocrinology 122 :602, (1988).
  • 17. Leifer CE, Peteıson ME, Matus RE, Patnaik AK: Hypoglycemia associated with non-isle-cell tumors in 13 dogs, JAVMA 186:53,(1985).
  • 18. Ogilvie GK, Felsberg PJ. Harris SW: Short term effect of cyclophosphamide and azathioprine on the selected aspects of the canine immune system, J Vet Immunol Iınmunopathol 18: 119,(1988).
  • 19. Ogilvie GK, Walters LM, Fettman MJ: Energy expenditure in dogs with lymphoma fed two specialized diets, Cancer 71:31- 46,(1993).
  • 20. Krishnaswamy K: Effects of malnutrion on drug metabolism and toxicity in humans, Nurt Toxicol 2:105, (1987).
Toplam 20 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Bölüm Araştırma Makalesi
Yazarlar

İsmail Alkan Bu kişi benim

Loğman Aslan Bu kişi benim

Yayımlanma Tarihi 1 Haziran 2001
Yayımlandığı Sayı Yıl 2001 Cilt: 7 Sayı: 1-2

Kaynak Göster

APA Alkan, İ., & Aslan, L. (2001). Paraneoplastik sendromlar. Yüzüncü Yıl Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi, 7(1-2), 156-159.
AMA Alkan İ, Aslan L. Paraneoplastik sendromlar. Yüzüncü Yıl Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi. Haziran 2001;7(1-2):156-159.
Chicago Alkan, İsmail, ve Loğman Aslan. “Paraneoplastik Sendromlar”. Yüzüncü Yıl Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 7, sy. 1-2 (Haziran 2001): 156-59.
EndNote Alkan İ, Aslan L (01 Haziran 2001) Paraneoplastik sendromlar. Yüzüncü Yıl Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 7 1-2 156–159.
IEEE İ. Alkan ve L. Aslan, “Paraneoplastik sendromlar”, Yüzüncü Yıl Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi, c. 7, sy. 1-2, ss. 156–159, 2001.
ISNAD Alkan, İsmail - Aslan, Loğman. “Paraneoplastik Sendromlar”. Yüzüncü Yıl Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 7/1-2 (Haziran 2001), 156-159.
JAMA Alkan İ, Aslan L. Paraneoplastik sendromlar. Yüzüncü Yıl Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi. 2001;7:156–159.
MLA Alkan, İsmail ve Loğman Aslan. “Paraneoplastik Sendromlar”. Yüzüncü Yıl Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi, c. 7, sy. 1-2, 2001, ss. 156-9.
Vancouver Alkan İ, Aslan L. Paraneoplastik sendromlar. Yüzüncü Yıl Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi. 2001;7(1-2):156-9.
 Kapak Resmi İndir